Back to Search Start Over

Efficacy and Safety of a Once-Daily Fixed-Dose Combination of Abacavir/Lamivudine Compared With Abacavir Twice Daily and Lamivudine Once Daily as Separate Entities in Antiretroviral-Experienced HIV-1 -Infected Patients (CAL30001 Study).

Authors :
LaMarca, Anthony
Clumeck, Nathan
Plettenberg, Andreas
Domingo, Pere
Kaisong Fu
Craig, Charles
Zhao, Henry
Watson, Maria
Gordon, David
Scott, Trevor
Source :
JAIDS: Journal of Acquired Immune Deficiency Syndromes; 4/15/2006, Vol. 41 Issue 5, p598-606, 9p, 5 Charts, 2 Graphs
Publication Year :
2006

Details

Language :
English
ISSN :
15254135
Volume :
41
Issue :
5
Database :
Complementary Index
Journal :
JAIDS: Journal of Acquired Immune Deficiency Syndromes
Publication Type :
Academic Journal
Accession number :
20635863
Full Text :
https://doi.org/10.1097/01.qai.0000214821.33905.5c